103 related articles for article (PubMed ID: 38729430)
1. The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis.
Ali MK; Hussein RS; Abdallah KS; Mohamed AA
J Gynecol Obstet Hum Reprod; 2024 May; 53(7):102795. PubMed ID: 38729430
[TBL] [Abstract][Full Text] [Related]
2. Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis.
Ota K; Takahashi T; Shiraishi S; Mizunuma H
J Obstet Gynaecol Res; 2018 Sep; 44(9):1787-1792. PubMed ID: 29998482
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
Hirata T; Izumi G; Takamura M; Saito A; Nakazawa A; Harada M; Hirota Y; Koga K; Fujii T; Osuga Y
Gynecol Endocrinol; 2014 Oct; 30(10):726-9. PubMed ID: 24905725
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
Chen D; Ai G; Yang W; Liu J; Luo N; Guo J; Cheng Z
J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
[TBL] [Abstract][Full Text] [Related]
6. Guideline No. 437: Diagnosis and Management of Adenomyosis.
Dason ES; Maxim M; Sanders A; Papillon-Smith J; Ng D; Chan C; Sobel M
J Obstet Gynaecol Can; 2023 Jun; 45(6):417-429.e1. PubMed ID: 37244746
[TBL] [Abstract][Full Text] [Related]
7. The Outcome of Fertility-Sparing and Nonfertility-Sparing Surgery for the Treatment of Adenomyosis. A Systematic Review and Meta-analysis.
Mikos T; Lioupis M; Anthoulakis C; Grimbizis GF
J Minim Invasive Gynecol; 2020 Feb; 27(2):309-331.e3. PubMed ID: 31398415
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
Fawzy M; Mesbah Y
Arch Gynecol Obstet; 2015 Dec; 292(6):1267-71. PubMed ID: 25990480
[TBL] [Abstract][Full Text] [Related]
9. Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial.
Hassanin AI; Youssef AA; Yousef AM; Ali MK
Int J Gynaecol Obstet; 2021 Aug; 154(2):263-269. PubMed ID: 33454995
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis.
Yang S; Liu Y; Wen J; Sun Y; Ren F
Evid Based Complement Alternat Med; 2022; 2022():1995472. PubMed ID: 35873621
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Treatment for Symptomatic Adenomyosis: A Systematic Review.
Benetti-Pinto CL; Mira TAA; Yela DA; Teatin-Juliato CR; Brito LGO
Rev Bras Ginecol Obstet; 2019 Sep; 41(9):564-574. PubMed ID: 31546278
[TBL] [Abstract][Full Text] [Related]
12. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
[TBL] [Abstract][Full Text] [Related]
13. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion.
Kang L; Gong J; Cheng Z; Dai H; Liping H
J Minim Invasive Gynecol; 2009; 16(2):169-73. PubMed ID: 19249704
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Matsushima T; Akira S; Yoneyama K; Takeshita T
Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
[TBL] [Abstract][Full Text] [Related]
15. Non-surgical interventions for the management of chronic pelvic pain.
Cheong YC; Smotra G; Williams AC
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD008797. PubMed ID: 24595586
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
Miao J; Lu J; Tang J; Lu P
Gynecol Endocrinol; 2022 Aug; 38(8):656-660. PubMed ID: 35850637
[No Abstract] [Full Text] [Related]
17. [Efficacy of dienogest versus gonadotropin-releasing hormone agonist combined with dienogest sequential therapy in the treatment of adenomyosis].
Zhang HY; Zhu S; Xu W; Wang AQ; Wang XL
Zhonghua Fu Chan Ke Za Zhi; 2022 Nov; 57(11):856-863. PubMed ID: 36456483
[No Abstract] [Full Text] [Related]
18. [Analysis of the relationship between MRI imaging characteristics and clinical symptoms and therapeutic efficacy in adenomyosis patients].
Han XT; Guo HY; Wang F; Gao XR; Liu L; Wang ML
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):343-350. PubMed ID: 37217341
[No Abstract] [Full Text] [Related]
19. Efficacy, Adverse Events, and Challenges of Dienogest in the Management of Symptomatic Adenomyosis: A Comparison with Different Hormonal Treatments.
Kobayashi H
Gynecol Obstet Invest; 2023; 88(2):71-80. PubMed ID: 36682346
[TBL] [Abstract][Full Text] [Related]
20. Long-term dienogest administration in patients with symptomatic adenomyosis.
Neriishi K; Hirata T; Fukuda S; Izumi G; Nakazawa A; Yamamoto N; Harada M; Hirota Y; Koga K; Wada-Hiraike O; Fujii T; Osuga Y
J Obstet Gynaecol Res; 2018 Aug; 44(8):1439-1444. PubMed ID: 29845696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
